Can melatonin be a potential “silver bullet” in treating covid-19 patients?

Abstract: The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract the consequences of COVID-19 infections has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the consequences of SARS-CoV-2 infection. Moreover, indirect evidence points out to a possible antiviral action of melatonin by interfering with SARS-CoV-2/angiotensin-converting enzyme 2 association. Melatonin is also an effective chronobiotic agent to reverse the circadian disruption of social isolation and to control delirium in severely affected patients. As a cytoprotector, melatonin serves to combat several comorbidities such as diabetes, metabolic syndrome, and ischemic and non-ischemic cardiovascular diseases, which aggravate COVID-19 disease. In view of evidence on the occurrence of neurological sequels in COVID-19-infected patients, another putative application of melatonin emerges based on its neuroprotective properties. Since melatonin is an effective means to control cognitive decay in minimal cognitive impairment, its therapeutic significance for the neurological sequels of SARS-CoV-2 infection should be considered. Finally, yet importantly, exogenous melatonin can be an adjuvant capable of augmenting the efficacy of anti-SARS-CoV-2 vaccines. We discuss in this review the experimental evidence suggesting that melatonin is a potential “silver bullet” in the COVID 19 pandemic.

Saved in:
Bibliographic Details
Main Authors: Cardinali, Daniel Pedro, Brown, Gregory M., Pandi Perumal, Seithikurippu R.
Format: Artículo biblioteca
Language:eng
Published: Multidisciplinary Digital Publishing Institute 2020
Subjects:ENVEJECIMIENTO, VACUNACION, COVID-19, SARS-CoV-2, DIABETES, INFLAMACION, SINDROME METABOLICO, MELATONINA, DETERIORO COGNITIVO, NEURODEGENERACION, ESTRES OXIDATIVO, SISTEMA RENINA-ANGIOTENSINA,
Online Access:https://repositorio.uca.edu.ar/handle/123456789/13665
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:ucacris:123456789-13665
record_format koha
spelling oai:ucacris:123456789-136652022-03-31T18:54:09Z Can melatonin be a potential “silver bullet” in treating covid-19 patients? Cardinali, Daniel Pedro Brown, Gregory M. Pandi Perumal, Seithikurippu R. ENVEJECIMIENTO VACUNACION COVID-19 SARS-CoV-2 DIABETES INFLAMACION SINDROME METABOLICO MELATONINA DETERIORO COGNITIVO NEURODEGENERACION ESTRES OXIDATIVO SISTEMA RENINA-ANGIOTENSINA Abstract: The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract the consequences of COVID-19 infections has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the consequences of SARS-CoV-2 infection. Moreover, indirect evidence points out to a possible antiviral action of melatonin by interfering with SARS-CoV-2/angiotensin-converting enzyme 2 association. Melatonin is also an effective chronobiotic agent to reverse the circadian disruption of social isolation and to control delirium in severely affected patients. As a cytoprotector, melatonin serves to combat several comorbidities such as diabetes, metabolic syndrome, and ischemic and non-ischemic cardiovascular diseases, which aggravate COVID-19 disease. In view of evidence on the occurrence of neurological sequels in COVID-19-infected patients, another putative application of melatonin emerges based on its neuroprotective properties. Since melatonin is an effective means to control cognitive decay in minimal cognitive impairment, its therapeutic significance for the neurological sequels of SARS-CoV-2 infection should be considered. Finally, yet importantly, exogenous melatonin can be an adjuvant capable of augmenting the efficacy of anti-SARS-CoV-2 vaccines. We discuss in this review the experimental evidence suggesting that melatonin is a potential “silver bullet” in the COVID 19 pandemic. 2022-03-22T11:45:06Z 2022-03-22T11:45:06Z 2020 Artículo Cardinali, D.P., Brown, G. M., Pandi Perumal, S. R. Can melatonin be a potential “silver bullet” in treating covid-19 patients? [en línea]. Diseases. 2020, 8 (4). doi: 10.3390/diseases8040044. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/13665 2079-9721 https://repositorio.uca.edu.ar/handle/123456789/13665 10.3390/diseases8040044 eng Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Multidisciplinary Digital Publishing Institute Diseases Vol. 8, No. 4, 2020
institution UCA
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-uca
tag biblioteca
region America del Sur
libraryname Sistema de bibliotecas de la UCA
language eng
topic ENVEJECIMIENTO
VACUNACION
COVID-19
SARS-CoV-2
DIABETES
INFLAMACION
SINDROME METABOLICO
MELATONINA
DETERIORO COGNITIVO
NEURODEGENERACION
ESTRES OXIDATIVO
SISTEMA RENINA-ANGIOTENSINA
ENVEJECIMIENTO
VACUNACION
COVID-19
SARS-CoV-2
DIABETES
INFLAMACION
SINDROME METABOLICO
MELATONINA
DETERIORO COGNITIVO
NEURODEGENERACION
ESTRES OXIDATIVO
SISTEMA RENINA-ANGIOTENSINA
spellingShingle ENVEJECIMIENTO
VACUNACION
COVID-19
SARS-CoV-2
DIABETES
INFLAMACION
SINDROME METABOLICO
MELATONINA
DETERIORO COGNITIVO
NEURODEGENERACION
ESTRES OXIDATIVO
SISTEMA RENINA-ANGIOTENSINA
ENVEJECIMIENTO
VACUNACION
COVID-19
SARS-CoV-2
DIABETES
INFLAMACION
SINDROME METABOLICO
MELATONINA
DETERIORO COGNITIVO
NEURODEGENERACION
ESTRES OXIDATIVO
SISTEMA RENINA-ANGIOTENSINA
Cardinali, Daniel Pedro
Brown, Gregory M.
Pandi Perumal, Seithikurippu R.
Can melatonin be a potential “silver bullet” in treating covid-19 patients?
description Abstract: The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract the consequences of COVID-19 infections has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the consequences of SARS-CoV-2 infection. Moreover, indirect evidence points out to a possible antiviral action of melatonin by interfering with SARS-CoV-2/angiotensin-converting enzyme 2 association. Melatonin is also an effective chronobiotic agent to reverse the circadian disruption of social isolation and to control delirium in severely affected patients. As a cytoprotector, melatonin serves to combat several comorbidities such as diabetes, metabolic syndrome, and ischemic and non-ischemic cardiovascular diseases, which aggravate COVID-19 disease. In view of evidence on the occurrence of neurological sequels in COVID-19-infected patients, another putative application of melatonin emerges based on its neuroprotective properties. Since melatonin is an effective means to control cognitive decay in minimal cognitive impairment, its therapeutic significance for the neurological sequels of SARS-CoV-2 infection should be considered. Finally, yet importantly, exogenous melatonin can be an adjuvant capable of augmenting the efficacy of anti-SARS-CoV-2 vaccines. We discuss in this review the experimental evidence suggesting that melatonin is a potential “silver bullet” in the COVID 19 pandemic.
format Artículo
topic_facet ENVEJECIMIENTO
VACUNACION
COVID-19
SARS-CoV-2
DIABETES
INFLAMACION
SINDROME METABOLICO
MELATONINA
DETERIORO COGNITIVO
NEURODEGENERACION
ESTRES OXIDATIVO
SISTEMA RENINA-ANGIOTENSINA
author Cardinali, Daniel Pedro
Brown, Gregory M.
Pandi Perumal, Seithikurippu R.
author_facet Cardinali, Daniel Pedro
Brown, Gregory M.
Pandi Perumal, Seithikurippu R.
author_sort Cardinali, Daniel Pedro
title Can melatonin be a potential “silver bullet” in treating covid-19 patients?
title_short Can melatonin be a potential “silver bullet” in treating covid-19 patients?
title_full Can melatonin be a potential “silver bullet” in treating covid-19 patients?
title_fullStr Can melatonin be a potential “silver bullet” in treating covid-19 patients?
title_full_unstemmed Can melatonin be a potential “silver bullet” in treating covid-19 patients?
title_sort can melatonin be a potential “silver bullet” in treating covid-19 patients?
publisher Multidisciplinary Digital Publishing Institute
publishDate 2020
url https://repositorio.uca.edu.ar/handle/123456789/13665
work_keys_str_mv AT cardinalidanielpedro canmelatoninbeapotentialsilverbulletintreatingcovid19patients
AT browngregorym canmelatoninbeapotentialsilverbulletintreatingcovid19patients
AT pandiperumalseithikurippur canmelatoninbeapotentialsilverbulletintreatingcovid19patients
_version_ 1756276476851781632